Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIONEER-HF: Sacubitril/Valsartan in ADHF
NCT02554890Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure (HF), sponsored by Novartis. Started Apr 2016; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02554890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554890.